Irinotecan,Leucovorin,Gemcitabine,Nab-paclitaxel
ipsen
[]
nice positive results for first line pdac in a phase iii trial. more indirect evidence for choosing first line folfirinox/nalirifox #gi23 
GI oncologist @SHEBA interests- pancreatic cancer, clinical trials